A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity

Figure 4

The expression of SLC12A5in tumor specimens with different stages in (a) COAD, (b) ESCA, (c) KIRC, (d) PAAD, (e) READ, and (f) TGCT.

(a)

(b)

(c)

(d)

(e)

(f)